Dashboard
Financial statements
HSIC

Company financials

Henry Schein

Health Care Health Care Distributors Melville, New York Last filing Feb 24, 2026 · FY2025
Revenue FY2025
$13.2B
3y CAGR +1.4% P24
Net income FY2025
$398.0M
Net margin +3.0% P25
Total assets FY2025
$11.2B
ROA +3.5% P28
Operating cash flow FY2025
$712.0M
18 yrs · FY2008–FY2025 9 filed · 0 derived · 0 blank

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

29 accounts · 5 years
Total assets $11.2B
Total liabilities $6.4B
Shareholders equity $3.2B
Account 2025 2024 2023 2022 2021 Trend
Assets
Cash and Cash Equivalents 1.2% 1.0% 1.4% 0.9% 1.0%
Accounts Receivable 12.5% 11.7% 15.1% 11.4% 11.7%
Inventory 15.2% 15.5%
Prepaid Expenses 5.0% 3.7%
Total Current Assets 33.9% 31.4% 36.4% 31.5% 31.0%
Property,Plant and Equipment 4.7% 15.5% 15.7% 3.0% 3.0%
Operating Lease Assets 2.3% 2.3% 2.6% 2.2% 2.6%
Goodwill 32.0% 30.7% 31.4% 22.9% 23.0%
Intangible Assets 7.7% 4.6%
Total Assets 85.1% 80.6% 85.7% 68.1% 68.4%
Liabilities
Accounts Payable 8.8% 7.6% 8.3% 7.9% 8.5%
Accrued Liabilities 2.6% 2.4% 2.7% 2.5% 3.1%
Current Portion of Long Term Debt 5.8% 0.8%
Operating Lease Liabilities 0.6% 0.6%
Other Current Liabilities 5.2% 4.9% 5.7% 4.7% 4.8%
Total Current Liabilities 24.5% 22.1% 21.7% 17.6% 18.6%
Deferred Revenue Noncurrent 0.1% 0.1%
Operating Lease Liabilities Noncurrent 1.9% 2.0% 2.5% 2.2% 2.2%
Deferred Tax Liabilities 1.1% 0.3%
Other Noncurrent Liabilities 3.7% 3.1% 3.5% 2.9% 3.0%
Total Liabilities 48.7% 42.5% 43.9% 31.1% 30.7%
Equity
Preferred Stock 0.0% 0.0% 0.0% 0.0% 0.0%
Common Stock 0.0% 4.8% 4.9% 0.0% 5.0%
Additional Paid In Capital 1.3% 0.0% 0.0% 0.0% 0.0%
Retained Earnings 25.0% 29.1%
Accumulated Other Comprehensive Income -1.7% -1.8%
Noncontrolling Interest 5.0% 5.1%
Total Stockholders Equity 24.6% 26.8% 29.6% 27.2% 27.6%
Total Liabilitiesand Equity 85.1% 69.2% 73.5% 68.1% 58.3%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 5 years
Ratio 2025 2024 2023 2022 2021
Profitability
Gross margin +31.1% +31.7% +31.3% +30.3% +29.6%
Operating margin +5.0% +4.9% +5.0% +5.9% +6.9%
Net margin +3.0% +3.1% +3.4% +4.3% +5.1%
FCF margin +5.5% +2.9% +5.1%
Growth
Revenue CAGR (3y) +1.4% +0.7% +6.8% +8.2% +9.6%
Returns
ROE +12.3% +11.5% +11.4% +15.6% +18.4%
ROA +3.5% +3.8% +3.9% +6.3% +7.4%
ROIC +12.9% +18.7% +16.9% +16.6% +25.7%
Liquidity
Current ratio 1.38x 1.42x 1.67x 1.79x 1.67x
Quick ratio 0.56x 0.57x 0.76x 0.70x 0.68x
Leverage
D/E 1.98x 1.59x 1.48x 1.14x 1.11x
Interest coverage 4.35x 4.74x 7.07x 21.34x 31.56x
Efficiency
Asset turnover 1.18x 1.24x 1.17x 1.47x 1.46x
Cash conversion cycle +80d +78d +89d +81d +76d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched
Saving notes adds HSIC to your watchlist.